NO20025124D0 - Metode - Google Patents

Metode

Info

Publication number
NO20025124D0
NO20025124D0 NO20025124A NO20025124A NO20025124D0 NO 20025124 D0 NO20025124 D0 NO 20025124D0 NO 20025124 A NO20025124 A NO 20025124A NO 20025124 A NO20025124 A NO 20025124A NO 20025124 D0 NO20025124 D0 NO 20025124D0
Authority
NO
Norway
Prior art keywords
production
hyperpolarized
relates
present
contrast agent
Prior art date
Application number
NO20025124A
Other languages
English (en)
Inventor
JAN HENRIK ARDENKJµR-LARSEN
Haukur Johannesson
Rolf Servin
Lars-G÷Ran Wistrand
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Health As filed Critical Amersham Health As
Priority to NO20025124A priority Critical patent/NO20025124D0/no
Publication of NO20025124D0 publication Critical patent/NO20025124D0/no
Priority to PCT/NO2003/000352 priority patent/WO2004037296A2/en
Priority to JP2004546566A priority patent/JP4420224B2/ja
Priority to DE60308066T priority patent/DE60308066T2/de
Priority to ES03759106T priority patent/ES2274272T3/es
Priority to EP03759106A priority patent/EP1583563B1/en
Priority to CA002500542A priority patent/CA2500542A1/en
Priority to AU2003274845A priority patent/AU2003274845B2/en
Priority to AT03759106T priority patent/ATE337796T1/de
Priority to KR1020057006967A priority patent/KR20050074495A/ko
Priority to RU2005109267/15A priority patent/RU2337059C2/ru
Priority to US10/532,563 priority patent/US8003077B2/en
Priority to CNB2003801017512A priority patent/CN100435852C/zh
Priority to NO20051737A priority patent/NO20051737L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B23/00—Noble gases; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206—Administration of radioactive gases, aerosols or breath tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Atmospheric Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Semiconductor Lasers (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
NO20025124A 2002-10-25 2002-10-25 Metode NO20025124D0 (no)

Priority Applications (14)

Application Number Priority Date Filing Date Title
NO20025124A NO20025124D0 (no) 2002-10-25 2002-10-25 Metode
CNB2003801017512A CN100435852C (zh) 2002-10-25 2003-10-24 超极化129Xe的制备方法
CA002500542A CA2500542A1 (en) 2002-10-25 2003-10-24 Method for the production of hyperpolarized 129xe
JP2004546566A JP4420224B2 (ja) 2002-10-25 2003-10-24 過分極１２９Ｘｅの製造法
DE60308066T DE60308066T2 (de) 2002-10-25 2003-10-24 Verfahren zur herstellung von hyperpolarisiertem 129xe
ES03759106T ES2274272T3 (es) 2002-10-25 2003-10-24 Procedimiento para la produccion de 129xe hiperpolarizado.
EP03759106A EP1583563B1 (en) 2002-10-25 2003-10-24 Method for the production of hyperpolarized 129xe
PCT/NO2003/000352 WO2004037296A2 (en) 2002-10-25 2003-10-24 Method for the production of hyperpolarized 129xe
AU2003274845A AU2003274845B2 (en) 2002-10-25 2003-10-24 Method for the production of hyperpolarized 129Xe
AT03759106T ATE337796T1 (de) 2002-10-25 2003-10-24 Verfahren zur herstellung von hyperpolarisiertem 129xe
KR1020057006967A KR20050074495A (ko) 2002-10-25 2003-10-24 초편극화된 129ｘｅ의 제조 방법
RU2005109267/15A RU2337059C2 (ru) 2002-10-25 2003-10-24 СПОСОБ ПРИГОТОВЛЕНИЯ ГИПЕРПОЛЯРИЗОВАННОГО 129Xe
US10/532,563 US8003077B2 (en) 2002-10-25 2003-10-24 Method for the production of hyperpolarized 129Xe
NO20051737A NO20051737L (no) 2002-10-25 2005-04-08 Method for the production of hyperpolarized 129XE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20025124A NO20025124D0 (no) 2002-10-25 2002-10-25 Metode

Publications (1)

Publication Number Publication Date
NO20025124D0 true NO20025124D0 (no) 2002-10-25

Family

ID=19914117

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025124A NO20025124D0 (no) 2002-10-25 2002-10-25 Metode

Country Status (12)

Country Link
US (1) US8003077B2 (no)
EP (1) EP1583563B1 (no)
JP (1) JP4420224B2 (no)
KR (1) KR20050074495A (no)
CN (1) CN100435852C (no)
AT (1) ATE337796T1 (no)
CA (1) CA2500542A1 (no)
DE (1) DE60308066T2 (no)
ES (1) ES2274272T3 (no)
NO (1) NO20025124D0 (no)
RU (1) RU2337059C2 (no)
WO (1) WO2004037296A2 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3998243B2 (ja) * 2003-01-10 2007-10-24 東横化学株式会社 核スピン偏極キセノンガスの製造方法及び製造装置
BRPI0622085B8 (pt) * 2005-04-06 2021-06-22 Liebel Flarsheim Co Llc conjunto de injeção de fluido médico e método para sua utilização
US8703102B2 (en) 2008-04-04 2014-04-22 Millikelvin Technologies Llc Systems and methods for producing hyperpolarized materials and mixtures thereof
WO2007136439A2 (en) * 2006-02-21 2007-11-29 Avrum Belzer Hyperpolarization methods, systems and compositions
WO2007149454A2 (en) * 2006-06-19 2007-12-27 Beth Isreal Deaconess Medical Center, Inc. Imaging agents for use in magnetic resonance blood flow/perfusion imaging
US9289518B2 (en) * 2008-08-22 2016-03-22 The Brigham And Women's Hospital Enhanced 13C NMR by thermal mixing with hyperpolarized 129XE
US8697034B2 (en) * 2008-10-10 2014-04-15 The Board Of Regents Of The University Of Texas System Hyperpolarized 89-yttrium and methods relating thereto
US20100251732A1 (en) * 2009-04-06 2010-10-07 General Electric Company Apparatus and method for introduction of a material into a cryogenic system
ES2375390B1 (es) * 2009-10-26 2013-02-11 Consejo Superior De Investigaciones Científicas (Csic) Planta de recuperación de helio.
EP2348327B1 (en) * 2010-01-18 2013-11-27 Bruker BioSpin AG Method for NMR measurements using dissolution dynamic nuclear polarization (DNP) with elimination of free radicals
CN101961051A (zh) * 2010-09-08 2011-02-02 营口艾特科技有限公司 含氙气的液体及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126347A (en) * 1996-03-29 2003-11-23 Lawrence Berkeley National Lab Enhancement of nmr and mri in the presence of hyperpolarized noble gases
CN1224502A (zh) * 1996-03-29 1999-07-28 劳伦斯·伯克利国家实验室 利用超极化惰性气体对于核磁共振和磁共振成象质量的提高
CA2290808A1 (en) 1997-06-19 1998-12-23 Jan Henrik Ardenkjaer-Larsen Overhauser magnetic resonance imaging (ormi) method comprising ex vivo polarization of a magnetic resonance (mr) imaging agent
US6278893B1 (en) 1998-01-05 2001-08-21 Nycomed Imaging As Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent
US6125654A (en) 1998-10-16 2000-10-03 Syracuse University Bulk production and usage of hyperpolarized 129 Xenon
GB0001727D0 (en) 2000-01-25 2000-03-15 Oxford Instr Uk Ltd Hyperpolarization of a noble gas

Also Published As

Publication number Publication date
RU2337059C2 (ru) 2008-10-27
US8003077B2 (en) 2011-08-23
WO2004037296A3 (en) 2005-08-18
AU2003274845A1 (en) 2004-05-13
EP1583563B1 (en) 2006-08-30
ES2274272T3 (es) 2007-05-16
KR20050074495A (ko) 2005-07-18
CA2500542A1 (en) 2004-05-06
ATE337796T1 (de) 2006-09-15
US20060173282A1 (en) 2006-08-03
CN100435852C (zh) 2008-11-26
RU2005109267A (ru) 2005-12-10
DE60308066D1 (de) 2006-10-12
DE60308066T2 (de) 2007-04-12
JP2006503638A (ja) 2006-02-02
JP4420224B2 (ja) 2010-02-24
EP1583563A2 (en) 2005-10-12
CN1713925A (zh) 2005-12-28
WO2004037296A2 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
DE60316538D1 (de) Dihydrobenzodiazepin-2-on-derivative für die behandlung von neurologischen erkrankungen
MX2007001035A (es) Metodo para producir una composicion, la composicion y su uso.
IS6069A (is) N-cýanómetýlamíð sem próteasalatar
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
ATE349446T1 (de) Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel
PL1646634T3 (pl) Zastosowanie rapamycyny i pochodnych rapamycyny w leczeniu utraty kości
IS8071A (is) Aðferð við meðhöndlun á hnútahersli, fitudreyra og tengdum ástands tegundum og lyfjafræðilegum samsetningum
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
MXPA06000123A (es) Suspension aislante de apoyo central de resorte rapido de plastico y metodo para fabricar y ensamblar el mismo.
ATE441630T1 (de) Substituierte cyclopenten-verbindungen
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
NO20025124D0 (no) Metode
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
TR200402030T4 (tr) İkame edilen I-aminobutan-3-ol-türevleri
ATE381920T1 (de) Retinolderivate und verfahren zu deren herstellung
ITMI20032172A1 (it) Procedimento atto alla correzione dell'arricchimento di
NO20024755D0 (no) Metode
DE60130659D1 (de) Therapeutische verbindungen und verfahren
DE60308966D1 (de) Vorrichtung für die Zufuhr von Atemgas
SG144921A1 (en) Method and intermediates for the preparation of derivatives of n-(1- benzhydrylazetidin-3-yl)-n-phenylmethylsulphonamide
DE60322395D1 (de) Antipruritisches mittel
DE50309647D1 (de) Ng fibrotischer erkrankungen
NO20051737L (no) Method for the production of hyperpolarized 129XE